2025-12-06 - Analysis Report
Here's a comprehensive report on Sempra (SRE), incorporating the provided data and analysis:

**1. Return Rate Comparison**

*   **Company Overview:** Sempra is an energy infrastructure company focused on regulated utilities and infrastructure in North America.
*   **SRE Cumulative Return:** 17.16%
*   **VOO (S&P 500) Cumulative Return:** 100.58%
*   **Divergence:**
    *   Current: -79.5
    *   Relative Divergence: 12.3 (meaning it's near the lower end of its historical divergence range)

**Analysis:** Sempra has significantly underperformed the S&P 500 over the examined period. The relative divergence indicates that this underperformance is relatively large compared to Sempra's own historical divergence range vs. VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2015-2017  | 8.0%    | 70.6%   | -20.0%  | 0.0    | 34.9   |
| 2016-2018  | 11.0%   | 71.1%   | -4.0%   | 0.1    | 35.3   |
| 2017-2019  | 35.0%   | 71.1%   | 13.0%   | 0.3    | 49.4   |
| 2018-2020  | -4.0%   | 80.1%   | -28.0%  | 0.2    | 41.5   |
| 2019-2021  | -2.0%   | 80.1%   | -49.0%  | 0.4    | 43.1   |
| 2020-2022  | -15.0%  | 81.1%   | -14.0%  | 0.4    | 50.4   |
| 2021-2023  | 22.0%   | 81.1%   | 20.0%   | 0.5    | 48.7   |
| 2022-2024  | 11.0%   | 81.1%   | -10.0%  | 0.6    | 57.2   |
| 2023-2025  | -12.0%  | 74.5%   | -77.0%  | -0.1   | 59.2   |

**Analysis:**

*   **CAGR:** Fluctuates significantly, indicating inconsistent growth.
*   **MDD:** High Maximum Drawdown (MDD) values suggest substantial potential losses during downturns.
*   **Alpha:**  Generally negative, meaning SRE is underperforming relative to its risk (Beta). There are only two timeframes (2017-2019 and 2021-2023) where alpha is positive, indicating outperformance.
*   **Beta:** Low Beta values (close to 0) indicate that SRE's price is not strongly correlated with the overall market (S&P 500).
*   **Cap(B):** Company capitalization has generally been increasing over the past decade.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 90.73
*   **Last Market Data:** Price: 90.66, Previous Close: 90.07, Change: 0.66
*   **5-day SMA:** 92.186
*   **20-day SMA:** 92.3695
*   **60-day SMA:** 90.3062

**Analysis:** The current price is below both the 5-day and 20-day Simple Moving Averages (SMAs), suggesting a short-term downtrend. The price is slightly above the 60-day SMA, suggesting longer term neutrality.

**3. Indicators**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommendation)
*   **RSI:** 43.51 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.323 (Negative but close to zero. Indicates price may be nearing a short-term bottom)
*   **Hybrid Signal:** Cash 0% Buy 100% (Very Safe)
*   **Recent Divergence Change:** -3.8 (Short-term decline in relative performance)
*   **Expected Return:** -241.1% (Significantly negative expected return relative to the S&P 500).

**Analysis:**  The MRI suggests a medium level of investment risk. The RSI is neutral. The PPO is negative, but close to zero. The extremely negative expected return is a significant concern.

**4. Recent News & Significant Events**

*   **Positive Sentiment:** Several articles highlight Sempra as a "top pick" and revisit its valuation after a period of price increase, suggesting positive near-term sentiment. SDG&E's reliability award is also a positive signal.
*   **Institutional Investment:** Marshall Wace LLP's purchase of shares indicates confidence from a major institutional investor.
*   **Financial Prospects Study:** Articles analyzing Sempra's financial prospects suggest a deeper look is warranted.
*   **External Market Conditions:** One article addresses the broader question of whether we are in a stock bubble.

**Analysis:** Recent news presents a mixed picture. While some articles express positive sentiment and point to potential value, others suggest a more cautious approach, emphasizing the need for further analysis.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (~1.82 on a 1-5 scale)
*   **Target Price:** Average: 100.73, High: 115.00, Low: 87.00
*   **Recent Rating Changes:** (Empty, no information is provided)

**Analysis:** Analyst consensus is generally positive, with a "Buy" rating and a target price above the current market price. Lack of recent rating changes suggests that analysts' opinions haven't changed recently.

**5. Recent Earnings Analysis**

| 날짜        | EPS   | 매출      |
|-------------|-------|-----------|
| 2025-11-05  | 0.12  | 2.76 B$  |
| 2025-08-07  | 0.71  | 2.70 B$  |
| 2025-05-08  | 1.39  | 3.68 B$  |
| 2024-11-06  | 1.01  | 2.57 B$  |
| 2025-11-05  | 1.01  | 2.57 B$  |

**Analysis:** EPS has been volatile, with the most recent EPS being significantly lower than previous quarters. Revenue has also fluctuated. This inconsistency in earnings performance is a point of concern. Notice also that there are duplicate dates.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30  | $3.15B     | 42.94%        |
| 2025-06-30  | $3.00B     | 46.73%        |
| 2025-03-31  | $3.80B     | 47.21%        |
| 2024-12-31  | $3.76B     | 49.23%        |
| 2024-09-30  | $2.78B     | 44.49%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE   |
|--------------|------------|-------|
| 2025-09-30  | $31.17B    | 0.30% |
| 2025-06-30  | $31.72B    | 1.49% |
| 2025-03-31  | $31.66B    | 2.90% |
| 2024-12-31  | $31.24B    | 2.16% |
| 2024-09-30  | $29.72B    | 2.18% |

**Analysis:**

*   **Revenue:** Fluctuating revenues with a recent downtick.
*   **Profit Margin:** Solid and generally high profit margins, but showing a slight recent decrease.
*   **Equity:** Relatively stable equity, indicating consistent asset base.
*   **ROE:** Return on Equity is volatile, with a significant drop in the most recent quarter, suggesting lower profitability from equity investments.

**7. Comprehensive Analysis (Summary)**

*   **Underperformance:** Sempra has significantly underperformed the S&P 500, and its relative divergence suggests this underperformance is historically significant.
*   **Inconsistent Growth:** CAGR and EPS have been volatile, indicating inconsistent growth patterns.
*   **High Risk:** High MDD values suggest potential for large losses during market downturns.
*   **Neutral Technicals:** RSI and PPO are near neutral values.
*   **Analyst Optimism:** Analysts are generally positive on Sempra, with a "Buy" rating and a target price above the current market price.
*   **Mixed News:** Recent news provides a mixed picture, with some articles highlighting positive aspects and others suggesting caution.
*   **Declining Profitability:** Most recent ROE and EPS figures are weak, suggesting potential challenges to future profitability.

**Conclusion:** While Sempra has shown some strengths in terms of profit margins, recent indicators point to weakening performance. The negative expected return, underperformance compared to the S&P 500, and volatile earnings figures raise concerns. Although analyst sentiment is generally positive, a cautious approach is warranted. Further research and monitoring of Sempra's financial performance are recommended before making an investment decision.



**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.